Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;37(7):e3449.
doi: 10.1002/dmrr.3449. Epub 2021 Mar 24.

Hypoglycaemia detection and prediction techniques: A systematic review on the latest developments

Affiliations

Hypoglycaemia detection and prediction techniques: A systematic review on the latest developments

Omar Diouri et al. Diabetes Metab Res Rev. 2021 Oct.

Abstract

The main objective of diabetes control is to correct hyperglycaemia while avoiding hypoglycaemia, especially in insulin-treated patients. Fear of hypoglycaemia is a hurdle to effective correction of hyperglycaemia because it promotes under-dosing of insulin. Strategies to minimise hypoglycaemia include education and training for improved hypoglycaemia awareness and the development of technologies to allow their early detection and thus minimise their occurrence. Patients with impaired hypoglycaemia awareness would benefit the most from these technologies. The purpose of this systematic review is to review currently available or in-development technologies that support detection of hypoglycaemia or hypoglycaemia risk, and identify gaps in the research. Nanomaterial use in sensors is a promising strategy to increase the accuracy of continuous glucose monitoring devices for low glucose values. Hypoglycaemia is associated with changes on vital signs, so electrocardiogram and encephalogram could also be used to detect hypoglycaemia. Accuracy improvements through multivariable measures can make already marketed galvanic skin response devices a good noninvasive alternative. Breath volatile organic compounds can be detected by dogs and devices and alert patients at hypoglycaemia onset, while near-infrared spectroscopy can also be used as a hypoglycaemia alarms. Finally, one of the main directions of research are deep learning algorithms to analyse continuous glucose monitoring data and provide earlier and more accurate prediction of hypoglycaemia. Current developments for early identification of hypoglycaemia risk combine improvements of available 'needle-type' enzymatic glucose sensors and noninvasive alternatives. Patient usability will be essential to demonstrate to allow their implementation for daily use in diabetes management.

Keywords: algorithms; devices; diabetes mellitus; hypoglycaemia; sensors.

PubMed Disclaimer

Conflict of interest statement

Omar Diouri, Monika Cigler and Martina Vettoretti reports no conflict of interests. Julia K. Mader is co‐founder and shareholder of decide Clinical Software GmbH. Julia K. Mader is a member in the advisory board of Boehringer Ingelheim, Eli Lilly, Medtronic, Prediktor A/S, Roche Diabetes Care, Sanofi‐Aventis and received speaker honoraria from Abbott Diabetes Care, Astra Zeneca, Dexcom, Eli Lilly, MSD, NovoNordisk A/S, Roche Diabetes Care, Sanofi, Servier and Takeda. Eric Renard reports consulting services to Abbott, Air Liquide SI, Cellnovo, Dexcom, Eli‐Lilly, Insulet, Johnson & Johnson (Animas, LifeScan), Medirio, Medtronic, Novo‐Nordisk, Roche and Sanofi and research support from Abbott, Dexcom, Insulet, Roche et Tandem. Pratik Choudhary has received speaker and consultancy fees from Novo Nordisk, Sanofi, Lilly, Insulet, Medtronic, Abbott, Diabits, Novartis and research support from Medtronic, Abbottm, Novo Nordisk and Dexcom.

Figures

FIGURE 1
FIGURE 1
Mapping of hypoglycaemia detection and prediction techniques
FIGURE 2
FIGURE 2
PRISMA flow diagram
FIGURE 3
FIGURE 3
Process from glucose sensing to hypoglycaemic event alert found in many available devices
FIGURE 4
FIGURE 4
Multivariable blood glucose prediction. In addition to glucose value, others inputs are added to increase accuracy. A blood glucose prediction value is calculated, and classification rules allow evaluating the incoming hypoglycaemia event
FIGURE 5
FIGURE 5
Multivariable event prediction. In this other model, the algorithm is trained directly for hypoglycaemia event prediction
FIGURE 6
FIGURE 6
Illustration of interindividual differences in heartbeats during hypoglycaemia events. The solidlines represent the mean of all the heartbeats that correspond to each subject in the training dataset: green during normal glucose levels, red during hypoglycaemic events. The comparison among four different subjects highlighted the fact that each subject may have a different ECG waveform during hypoglycaemic events. For instance, Subjects 1 and 2 present a visibly longer QT interval during hypoglycaemic events, differently from Subjects 3 and 4. Reproduced from Porumb et al.
FIGURE 7
FIGURE 7
Encephalogram (EEG) segments during euglycaemia and hypoglycaemia. Each segment represents a 5‐s interval of EEG recordings during each phase, showing a higher amplitude in the low‐frequency bands and greater regularity during hypoglycaemia episodes

References

    1. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a Workgroup of the American Diabetes Association and the Endocrine Society. J Clin Endocrinol Metab. 2013;98(5):1845‐1859. 10.1210/jc.2012-4127. - DOI - PubMed
    1. Gonder‐Frederick LA, Vajda KA, Schmidt KM, et al. Examining the behaviour subscale of the hypoglycaemia fear survey: an international study. Diabet Med. 2013;30(5):603‐609. 10.1111/dme.12129. - DOI - PubMed
    1. Bode BW, Schwartz S, Stubbs HA, Block JE. Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care. 2005;28(10):2361‐2366. 10.2337/diacare.28.10.2361. - DOI - PubMed
    1. International Hypoglycaemia Study Group . Glucose concentrations of less than 3.0 mmol/L (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care. 2017;40(1):155‐157. 10.2337/dc16-2215. - DOI - PubMed
    1. Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631‐1640. 10.2337/dc17-1600. - DOI - PMC - PubMed

Publication types